PPCB
Propanc Biopharma, Inc.
NASDAQ · Healthcare · Biotechnology · AU
$0.32
−7.31%Latest reported
- Last report date
- Oct 5, 2026
- EPS actual
- -$1.38
- EPS estimate
- —
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- —
- EPS misses (12Q)
- —
- EPS in line (12Q)
- —
- Avg surprise (4Q)
- —
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Oct 5, 2026 | — | -$1.38 | — | — |
| Sep 25, 2026 | — | -$1.38 | — | — |
| May 14, 2026 | — | -$0.28 | — | — |
| Nov 14, 2025 | — | -$0.39 | — | — |
| Sep 29, 2025 | — | -$0.35 | — | $29.9K |
| May 15, 2025 | — | -$13 | — | — |
| Feb 14, 2025 | — | -$32 | — | — |
| Nov 14, 2024 | — | -$288 | — | — |
| Sep 30, 2024 | — | -$253 | — | — |
| May 15, 2024 | — | -$625 | — | — |
| Feb 20, 2024 | — | -$1.9K | — | — |
| Nov 14, 2023 | — | -$2.5K | — | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 5, 2026